scholarly article | Q13442814 |
P356 | DOI | 10.1038/NRD4254 |
P698 | PubMed publication ID | 24625824 |
P2093 | author name string | Yasser Mushtaq | |
P2860 | cites work | Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials | Q44206747 |
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease | Q48487432 | ||
P433 | issue | 4 | |
P304 | page(s) | 253 | |
P577 | publication date | 2014-03-14 | |
P1433 | published in | Nature Reviews Drug Discovery | Q45998 |
P1476 | title | The COPD pipeline | |
P478 | volume | 13 |
Q28067306 | Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside |
Q35538521 | Effects of the novel BK (KCa 1.1) channel opener GoSlo-SR-5-130 are dependent on the presence of BKβ subunits |
Q90649853 | Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease |
Q41399925 | The COPD Pipeline XXIX. |
Q41400639 | The COPD Pipeline, XXV. |
Q41398563 | The COPD Pipeline, XXVI. |
Search more.